Reply: Biosimilars versus the originator of follitropin alfa in ART: eyes wide shut?

Affiliations

¹ Unit for Human Reproduction, 1st Department of Obstetrics and Gynaecology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Centre for Big Data Research in Health, Faculty of Medicine & Health, University of New South Wales, Sydney, NSW, Australia.
³ Fertility Associates, Auckland, New Zealand.
⁴ Department of Obstetrics and Gynecology, University of Monash, Monash, Clayton, VIC, Australia.

Editorial

Christos A Venetis et al. Hum Reprod. 2025.

. 2025 Sep 1;40(9):1793-1796.

doi: 10.1093/humrep/deaf145.

¹ Unit for Human Reproduction, 1st Department of Obstetrics and Gynaecology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Centre for Big Data Research in Health, Faculty of Medicine & Health, University of New South Wales, Sydney, NSW, Australia.
³ Fertility Associates, Auckland, New Zealand.
⁴ Department of Obstetrics and Gynecology, University of Monash, Monash, Clayton, VIC, Australia.

Erratum in

Correction to: Reply: Biosimilars versus the originator of follitropin alfa in ART: eyes wide shut?
[No authors listed] [No authors listed] Hum Reprod. 2025 Nov 19:deaf220. doi: 10.1093/humrep/deaf220. Online ahead of print. Hum Reprod. 2025. PMID: 41259780 No abstract available.

No abstract available

Follitropin alfa biosimilars: unfounded doubts on the road to reproductive care.
de Mora F, Howles CM, Trew G. de Mora F, et al. Hum Reprod. 2025 Sep 1;40(9):1789-1790. doi: 10.1093/humrep/deaf143. Hum Reprod. 2025. PMID: 40713789 Free PMC article. No abstract available.
Methodological concerns and clinical relevance: a critical appraisal of the meta-analysis on biosimilars versus originator follitropin alfa in ART.
Santulli P, Brandão P, D'Amato G, Grynberg M, Hamamah S, Luco MI, Marci R, Salle B, Freour T. Santulli P, et al. Hum Reprod. 2025 Sep 1;40(9):1791-1792. doi: 10.1093/humrep/deaf144. Hum Reprod. 2025. PMID: 40713809 No abstract available.

Biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART: a systematic review and meta-analysis.
Kiose KI, Storr A, Kolibianakis EM, Mol BW, Venetis CA. Kiose KI, et al. Hum Reprod. 2025 Feb 1;40(2):343-359. doi: 10.1093/humrep/deae274. Hum Reprod. 2025. PMID: 39719046 Free PMC article.
Follitropin alfa biosimilars: unfounded doubts on the road to reproductive care.
de Mora F, Howles CM, Trew G. de Mora F, et al. Hum Reprod. 2025 Sep 1;40(9):1789-1790. doi: 10.1093/humrep/deaf143. Hum Reprod. 2025. PMID: 40713789 Free PMC article. No abstract available.
Methodological concerns and clinical relevance: a critical appraisal of the meta-analysis on biosimilars versus originator follitropin alfa in ART.
Santulli P, Brandão P, D'Amato G, Grynberg M, Hamamah S, Luco MI, Marci R, Salle B, Freour T. Santulli P, et al. Hum Reprod. 2025 Sep 1;40(9):1791-1792. doi: 10.1093/humrep/deaf144. Hum Reprod. 2025. PMID: 40713809 No abstract available.